Search results for: 'Landscape of EdTech Solutions'

24 Oct 2018  |  North America  |  Market Research

Growth Opportunities in the Global Cell Therapy Market, Forecast to 2025

A Robust Product Pipeline Creating Opportunities for Ground-breaking Combination Therapies is Set to Revolutionize the Global Cell Therapy Market

Infographics

×

Key Issues Addressed

The global pharmaceuticals industry is continuously evolving to meet the requirements of a changing disease landscape. With the increasing prevalence of chronic infectious diseases and cancer, market needs are shifting from traditional small molecules to novel large molecule therapies, with cell therapies dominating the space. This study presents a...

This study focuses on the major trends, growth opportunities, drivers, and restraints of the personal protective equipment (PPE) market in South Africa, Kenya, and Nigeria. The study analyses the changing PPE landscape as end users look for cost-effective, functional PPE. The following segments are covered: above-the-neck protection, respiratory pr...

The North American refrigeration market is expected to witness healthy growth up to 2025. While there was a drop in revenues for 2018, the market is expected to move forward with increasing growth rates. The market is driven by an increasing demand for fresh food and chilled products, a replacement need for aging equipment, replacements due to tech...

The global loitering munitions (LM) market is undergoing rapid expansion as technological breakthroughs in autonomous guidance, miniaturized sensors, and artificial intelligence (AI)-driven targeting continue to redefine the tactical role of expendable strike systems. LMs offer a uniquely cost-effective alternative to traditional guided missiles, c...

31 Jul 2025  |  Global  |  Technology Research

Growth Opportunities in RNA Therapeutics

Broad Applications Drive Growth in RNA Therapeutics

Infographics

×

The report analyzes clinical trial activity across RNA therapeutic classes, including small interfering RNA (siRNA), messenger RNA (mRNA), antisense oligonucleotides (ASO), aptamers, micro RNA (miRNA), self-amplifying RNA (saRNA), small-activating RNA (RNAa), and circular RNA (cirRNA). It highlights key players in each segment and their role in adv...

The increasing volatility of global supply chains is driving interest in microfactories and distributed manufacturing. Manufacturers aim to improve production flexibility, reduce reliance on lengthy logistics routes, and enhance resilience in times of disruption. Traditionally, manufacturing networks have been optimized for centralized production, ...

Rare diseases pose a global burden to healthcare despite making up a very small fraction of the global disease landscape. Most treatment options for rare diseases focus on maintaining the disease symptoms, rather than a disease-modifying approach. To address this unmet need, RNA therapies are emerging as disease-modifying approaches addressing the ...

30 Apr 2020  |  Asia Pacific  |  Market Outlook

COVID-19—Implications for the Healthcare Industry, 2020

Winning Strategies and Key Opportunities that are Evolving During this Disruption

Infographics

×

A team of futurists, analysts, and consultants from the Global Transformational Health Research Team at Frost & Sullivan have come together to render a comprehensive analysis to predict the future of healthcare with COVID-19 disruption in perspective. This study provides actionable predictions and growth opportunities for major healthcare segments ...

12 Aug 2020  |  North America  |  Market Research

New Drug Development for Rare Pediatric Disorders Sustaining High Growth in the Global Orphan Drugs Market, 2019–2025

AI-powered Early Disease Diagnosis and Drug Repurposing will Create New Growth Opportunities

Infographics

×

Key Issues Addressed

Rare diseases have been an increasing area of focus as three waves have converged in recent years: genomic research and innovations becoming mainstream; the forthcoming regulatory policies and financial incentives put in place by the federal agencies; and the increasingly patient-centric and coordinated efforts of patient advocacy groups, caregive...